Trials / Sponsors / Intron Biotechnology, Inc.
Intron Biotechnology, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC0 Acute Radiation Syndrome | Phase 1 | 2018-06-11 |
| Completed | A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus | Phase 1 | 2018-02-07 |
| Terminated | Phase IIa Clinical Study of N-Rephasin® SAL200 Staphylococcus Aureus Bacteremia, Anti-Bacterial Agents | Phase 2 | 2017-03-07 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Vo Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus | Phase 1 | 2013-08-06 |